Formulation and validation of a baseline prognostic score for osteosarcoma treated uniformly with a non-high dose methotrexate-based protocol from a low middle income healthcare setting: a single centre analysis of 594 patients

Formulation and validation of a baseline prognostic score for osteosarcoma treated uniformly with a non-high dose methotrexate-based protocol from a low middle income healthcare setting: a single centre analysis of 594 patients

IntroductionThe outcomes of osteosarcoma in low middle income countries (LMICs) are different due to patients presenting in advanced stages, resource constraints and the use of non-high-dose-methotrexate (HDMTX)-based regimens. This study derived and validated a prognostic score for osteosarcoma tha...

Full description

Bibliographic Details
Main Authors: Shuvadeep Ganguly, Archana Sasi, Shah Alam Khan, Venkatesan Sampath Kumar, Love Kapoor, Mehar Chand Sharma, Asit Mridha, Adarsh Barwad, Sanjay Thulkar, Deepam Pushpam, Sameer Bakhshi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Oncology
Subjects:
prognostic
score
osteosarcoma
low middle income countries
bone sarcoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1148480/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1148480/full

Similar Items